Nandrolone and Telmisartan Interaction

Avoid
Mechanism-based 75% confidence

Nandrolone and Telmisartan have a potentially harmful interaction with 75% confidence. Both Nandrolone and Telmisartan carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Both compounds affect the heart, so monitoring these systems is recommended.

Compound Profiles

Nandrolone

Anabolic-Androgenic Steroid | Joint & Collagen Support

Nandrolone binds to the androgen receptor (AR) with affinity comparable to testosterone, promoting nitrogen retention, protein synthesis, and satellite cell activation in skeletal muscle tissue. Its anabolic effects are mediated through AR-dependent gene transcription that upregulates muscle-specific proteins including myosin heavy chain and IGF-1.

Half-life: ~6-12 days (decanoate) Typical dose: 100-200 mg/week (therapeutic) anabolic, healing, sexual health
5 alpha reductaseandrogen receptorigf1progesterone receptor androgenicblood pressure raisingcarcinogenic riskcardiotoxic
View full profile

Telmisartan

Angiotensin II Receptor Blocker | Cardiac Protection On Cycle

Telmisartan selectively blocks the angiotensin II type 1 (AT1) receptor, preventing angiotensin II from exerting its vasoconstrictive, aldosterone-secreting, and pro-fibrotic effects. By antagonizing AT1, telmisartan lowers systemic vascular resistance and blood pressure while simultaneously reducing pathological cardiac and vascular remodeling.

Half-life: ~24 hours Typical dose: 20-80 mg/day cardiovascular
ppar gamma blood pressure raisinghepatotoxicinsulin sensitizingteratogenic
View full profile

Combined Organ Load

Gonads
moderate
Heart
moderate
Blood Vessels
low
Liver
low

Shared Safety Flags

2x 2 compounds raise blood pressure (Nandrolone, Telmisartan). Monitor BP daily and consider cardiovascular support.
2x 2 hepatotoxic compounds (Nandrolone, Telmisartan). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 compounds share the teratogenic safety flag (Nandrolone, Telmisartan). Monitor accordingly.

Frequently Asked Questions

Can I take Nandrolone with Telmisartan?

Combining Nandrolone with Telmisartan is not recommended. Both Nandrolone and Telmisartan carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Is Nandrolone and Telmisartan safe together?

This combination carries significant risk. Both Nandrolone and Telmisartan carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.

What are the interactions between Nandrolone and Telmisartan?

Both Nandrolone and Telmisartan carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 75% confidence and is inferred from pharmacological mechanism analysis.

How should I time Nandrolone and Telmisartan?

Nandrolone has a half-life of ~6-12 days (decanoate) and Telmisartan has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Nandrolone vs Telmisartan

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.